Zhao, T., Metcalf, J., Yasin, M., Aldape, K., & Zadeh, G. (2017). GENE-38. DISRUPTED ENDOTHELIAL CELL GENE EXPRESSION PROFILE PREDICTS GBM CLINICAL RESPONSE TO ANTI-ANGIOGENIC THERAPY. Neuro Oncol.
Stile di citazione ChicagoZhao, Tansy, Julie Metcalf, Mamatjan Yasin, Ken Aldape, e Gelareh Zadeh. "GENE-38. DISRUPTED ENDOTHELIAL CELL GENE EXPRESSION PROFILE PREDICTS GBM CLINICAL RESPONSE TO ANTI-ANGIOGENIC THERAPY." Neuro Oncol 2017.
Citazione MLAZhao, Tansy, et al. "GENE-38. DISRUPTED ENDOTHELIAL CELL GENE EXPRESSION PROFILE PREDICTS GBM CLINICAL RESPONSE TO ANTI-ANGIOGENIC THERAPY." Neuro Oncol 2017.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.